Lupin Limited launches the United States Food and Drug Administration (FDA) approved sildenafil for oral suspension, 10 mg/mL in US market.
Sildenafil for oral suspension, 10 mg/mL, is a generic equivalent of Revatio for oral suspension, 10 mg/mL of Viatris Specialty LLC. Sildenafil for oral suspension (RLD Revatio) had estimated annual sales of US$ 64 million in the US.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
